Heart Failure in Atrial Fibrillation Subtypes in Women and Men in the Tromsø Study

Hilde Espnes1, Tom Wilsgaard1, Jocasta Ball2

  • 1Department of Community Medicine, UiT The Arctic University of Norway, Tromsø, Norway.

JACC. Advances
|January 29, 2025
PubMed

Insights

Atrial fibrillation (AF) increases heart failure (HF) risk in both sexes. Women with permanent AF face higher HF risk, while specific risk factors like smoking, hypertension, and obesity vary by sex, impacting mortality.

Area of Science:

  • Cardiology
  • Public Health
  • Sex-Specific Medicine

Background:

  • Atrial fibrillation (AF) and heart failure (HF) frequently coexist, significantly affecting patient morbidity and mortality.
  • Limited research exists on sex-specific associations between different atrial fibrillation subtypes and heart failure development.

Purpose of the Study:

  • To investigate sex-specific links between atrial fibrillation subtypes and subsequent heart failure.
  • To identify heart failure risk factors in individuals with atrial fibrillation, considering sex differences.
  • To explore the combined impact of atrial fibrillation and heart failure on all-cause mortality.

Main Methods:

  • Utilized data from 14,790 women and 13,181 men in the Tromsø Study (1994-2008) with follow-up through 2016.
  • Employed Cox regression analysis to calculate Hazard Ratios (HRs) and 95% Confidence Intervals (CIs) for incident AF and HF.
  • Analyzed sex-specific risk factors and mortality outcomes associated with AF subtypes and subsequent HF.

Main Results:

  • Individuals with AF exhibited an elevated risk of developing HF compared to those without AF, irrespective of sex.
  • Women with permanent AF showed a significantly higher relative risk of HF (HR: 10.52) than men (HR: 7.65).
  • Shared HF risk factors included smoking; sex-specific factors were hypertension and higher diastolic blood pressure in women, and underweight, obesity, and low alcohol intake in men. All-cause mortality was higher in women with AF and HF, and in men with paroxysmal/persistent AF.

Conclusions:

  • All atrial fibrillation subtypes are linked to an increased risk of heart failure.
  • Specific risk factors for heart failure in AF patients differ between sexes, with smoking being a common factor.
  • The presence of heart failure following atrial fibrillation significantly increases mortality risk for both men and women.
Abstract

Related Concept Videos

Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
1.5K
Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
311
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
375
Disturbances in Heart Rhythm01:28

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow...
886